Par Estro en es it fr

Par Estro Brand names, Par Estro Analogs

Par Estro Brand Names Mixture

  • Prempro (conjugated estrogens + medroxyprogesteron)

Par Estro Chemical_Formula

C18H21NaO5S

Par Estro RX_link

http://www.rxlist.com/cgi/generic/conest.htm

Par Estro fda sheet

Par_Estro FDA

Par Estro msds (material safety sheet)

Par_Estro MSDS

Par Estro Synthesis Reference

Bates, Cohen, U.S. Pat. 2,565,115 (1951)

Par Estro Molecular Weight

372.412 g/mol

Par Estro Melting Point

173 oC

Par Estro H2O Solubility

0.0036 mg/ml

Par Estro State

solid

Par Estro LogP

No information avaliable

Par Estro Dosage Forms

Tablet; Injection; Vaginal cream; Topical gel

Par Estro Indication

For the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)

Par Estro Pharmacology

Conjugated estrogens, a mixture of the water soluble salts of sulfate esters from estrone, equilin, 17 α-dihydroequilin, and other related steroids, may be derived from pregnant equine urine or yam and soy plants. Estrogens are important in the development and maintenance of the female reproductive system and secondary sex characteristics. They promote growth and development of the vagina, uterus, and fallopian tubes, and enlargement of the breasts. Indirectly, they contribute to the shaping of the skeleton, maintenance of tone and elasticity of urogenital structures, changes in the epiphyses of the long bones that allow for the pubertal growth spurt and its termination, growth of axillary and pubic hair, and pigmentation of the nipples and genitals. Decline of estrogenic activity at the end of the menstrual cycle can bring on menstruation, although the cessation of progesterone secretion is the most important factor in the mature ovulatory cycle. However, in the preovulatory or nonovulatory cycle, estrogen is the primary determinant in the onset of menstruation. Estrogens also affect the release of pituitary gonadotropins. The pharmacologic effects of conjugated estrogens are similar to those of endogenous estrogens.

Par Estro Absorption

Well absorbed

Par Estro side effects and Toxicity

Nausea and vomiting

Par Estro Patient Information

Par Estro Organisms Affected

Humans and other mammals